United Therapeutics Corp.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $3.96B | $894.8M |
| FY2022 | — | $4.80B | $961.2M |
| FY2023 | — | $5.98B | $1.21B |
| FY2024 | — | $6.44B | $1.70B |
| FY2025 | — | $7.10B | $1.56B |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $3.96B | $894.8M |
| FY2022 | — | $4.80B | $961.2M |
| FY2023 | — | $5.98B | $1.21B |
| FY2024 | — | $6.44B | $1.70B |
| FY2025 | — | $7.10B | $1.56B |